Status:
COMPLETED
Effect of Neuro Developmental Therapy in Infants With Down Syndrome
Lead Sponsor:
Riphah International University
Conditions:
Down Syndrome
Eligibility:
All Genders
5-3 years
Phase:
NA
Brief Summary
Neurodevelopmental treatments are a progressive therapeutic method experienced thru qualified therapists for the improvement in affected ones. The most important trial in Down syndrome children is mot...
Detailed Description
This study was a randomized trial design. This study was conducted in Rehab Care Physiotherapy Department. 20 Children with Down syndrome meeting the predetermined inclusive and exclusive criteria wer...
Eligibility Criteria
Inclusion
- Trisomy 21 by genetic karyotype.
- Down syndrome children with delayed milestone.
- Definite identification of Down syndrome by neurologist.
- Children having the average birth weight above 2.500 grams and average birth length above 49.52 cm.
- Laxity, low muscle tone and psychomotor development deficits
Exclusion
- Infants with Heart Defect.
- Seizure.
- Critical orthopedic difficulties or deformities (hip instability, patellar instability, foot deformity).
- Unrestrained thyroid conflicts.
- Perilabour asphyxia (Apgar of minutes 1 and 5 equal to or less than 7).
- Critical optical or acoustic disorders.
- Mass below the 3rd percentage of Down syndrome
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04816409
Start Date
March 15 2019
End Date
January 30 2020
Last Update
March 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Binash afzal
Lahore, Punjab Province, Pakistan, 54000